Transatlantic collaboration wants to know how impacts on innovation can be assessed
An international group of competition regulators that is examining mergers in the pharmaceutical industry has opened a public consultation on the subject, seeking views from academics and other experts.
Views submitted to the consultation will be used to develop a workshop that will be organised later this year, the European Commission said on 12 May. They must be submitted by 25 June.